It was demonstrated that a variable number of the IL-1Ra gene is not an independent risk factor for NSCLC, but it can play a role in prognosis when combined with polymorphisms of the IL-1β gene [3]. The gene discussed is IL1B; the disease is non-small cell lung carcinoma.